{"count": 4, "results": [{"_id": "40239400", "pmid": 40239400, "title": "The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor.", "journal": "Eur J Cancer", "authors": ["Shatila M", "Cruz CC", "Lu L", "Abdul-Baki K", "Baerman E", "Takigawa K", "Rivera AU", "Lee IJ", "Ngo S", "Sperling G", "Aleem AS", "Menon R", "Sullivan A", "Vemulapalli V", "Natha C", "Gupta T", "Khan A", "Mittal N", "Coleman G", "Salim H", "Wali S", "Varatharajalu K", "Kim KC", "Reddy SA", "Grivas P", "Thomas AS", "Wang Y"], "date": "2025-04-02T00:00:00Z", "doi": "10.1016/j.ejca.2025.115405", "meta_date_publication": "2025 Apr 2", "meta_volume": "221", "meta_issue": "", "meta_pages": "115405", "score": 50263.105, "text_hl": "We found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use may be associated with higher risk of @<m>DISEASE_CD59_Deficiency</m> @DISEASE_MESH:C567355 @@@IMC@@@. ", "citations": {"NLM": "Shatila M, Cruz CC, Lu L, Abdul-Baki K, Baerman E, Takigawa K, Rivera AU, Lee IJ, Ngo S, Sperling G, Aleem AS, Menon R, Sullivan A, Vemulapalli V, Natha C, Gupta T, Khan A, Mittal N, Coleman G, Salim H, Wali S, Varatharajalu K, Kim KC, Reddy SA, Grivas P, Thomas AS, Wang Y. The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor. Eur J Cancer. 2025 Apr 2;221():115405. PMID: 40239400", "BibTeX": "@article{40239400, title={The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor.}, author={Shatila M and Cruz CC and Lu L and Abdul-Baki K and Baerman E and Takigawa K and Rivera AU and Lee IJ and Ngo S and Sperling G and Aleem AS and Menon R and Sullivan A and Vemulapalli V and Natha C and Gupta T and Khan A and Mittal N and Coleman G and Salim H and Wali S and Varatharajalu K and Kim KC and Reddy SA and Grivas P and Thomas AS and Wang Y}, journal={Eur J Cancer}, volume={221}, pages={115405}}"}}, {"_id": "33689478", "pmid": 33689478, "title": "The intersection of metformin and inflammation.", "journal": "Am J Physiol Cell Physiol", "authors": ["Bharath LP", "Nikolajczyk BS"], "date": "2021-05-01T00:00:00Z", "doi": "10.1152/ajpcell.00604.2020", "meta_date_publication": "2021 May 1", "meta_volume": "320", "meta_issue": "5", "meta_pages": "C873-C879", "score": 50261.19, "text_hl": "In this study, we summarize the latest research on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s regulation of immune cell mitochondrial function and autophagy as evidence that new clinical trials on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ with primary outcomes related to the immune system should be considered to treat @<m>DISEASE_CD59_Deficiency</m> @DISEASE_MESH:C567355 @@@immune-mediated diseases@@@ over the near term.", "citations": {"NLM": "Bharath LP, Nikolajczyk BS. The intersection of metformin and inflammation. Am J Physiol Cell Physiol. 2021 May 1;320(5):C873-C879. PMID: 33689478", "BibTeX": "@article{33689478, title={The intersection of metformin and inflammation.}, author={Bharath LP and Nikolajczyk BS}, journal={Am J Physiol Cell Physiol}, volume={320}, number={5}, pages={C873-C879}}"}}, {"_id": "28606032", "pmid": 28606032, "title": "Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?", "journal": "Curr Drug Targets", "authors": ["Schuiveling M", "Vazirpanah N", "Radstake TRDJ", "Zimmermann M", "Broen JCA"], "date": "2018-01-01T00:00:00Z", "doi": "10.2174/1389450118666170613081730", "meta_date_publication": "2018", "meta_volume": "19", "meta_issue": "8", "meta_pages": "945-959", "score": 50078.21, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, A New Era for an Old Drug in the Treatment of @<m>DISEASE_CD59_Deficiency</m> @DISEASE_MESH:C567355 @@@Immune Mediated Disease@@@?", "citations": {"NLM": "Schuiveling M, Vazirpanah N, Radstake TRDJ, Zimmermann M, Broen JCA. Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease? Curr Drug Targets. 2018;19(8):945-959. PMID: 28606032", "BibTeX": "@article{28606032, title={Metformin, A New Era for an Old Drug in the Treatment of Immune Mediated Disease?}, author={Schuiveling M and Vazirpanah N and Radstake TRDJ and Zimmermann M and Broen JCA}, journal={Curr Drug Targets}, volume={19}, number={8}, pages={945-959}}"}}, {"_id": "29915588", "pmid": 29915588, "pmcid": "PMC5994909", "title": "Metformin and Autoimmunity: A \"New Deal\" of an Old Drug", "journal": "Front Immunol", "authors": ["Ursini F", "Russo E", "Pellino G", "D'Angelo S", "Chiaravalloti A", "De Sarro G", "Manfredini R", "De Giorgio R"], "date": "2018-06-04T00:00:00Z", "doi": "10.3389/fimmu.2018.01236", "meta_date_publication": "2018", "meta_volume": "9", "meta_issue": "", "meta_pages": "1236", "score": 50059.85, "text_hl": "These effects may represent a powerful contributor to antiaging and anticancer properties exerted by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and, from another standpoint, may open the way to assess whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can be a candidate molecule for clinical trials involving @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_CD59_Deficiency</m> @DISEASE_MESH:C567355 @@@immune-mediated diseases@@@. ", "citations": {"NLM": "Ursini F, Russo E, Pellino G, D'Angelo S, Chiaravalloti A, De Sarro G, Manfredini R, De Giorgio R. Metformin and Autoimmunity: A \"New Deal\" of an Old Drug Front Immunol. 2018;9():1236. PMID: 29915588", "BibTeX": "@article{29915588, title={Metformin and Autoimmunity: A \"New Deal\" of an Old Drug}, author={Ursini F and Russo E and Pellino G and D'Angelo S and Chiaravalloti A and De Sarro G and Manfredini R and De Giorgio R}, journal={Front Immunol}, volume={9}, pages={1236}}"}}]}